Clinical Practice Guideline for Common Bile Duct Stones: Diagnosis and Treatment

Sung III Jang; Dong Ki Lee

doi:10.4166/kjg.2018.72.1.6

Journal List > Korean J Gastroenterol > v.72(1) > 1099113

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Jang and Lee: Clinical Practice Guideline for Common Bile Duct Stones: Diagnosis and Treatment

Brief Summary of Practice Guideline

Korean J Gastroenterol 2018;72(1):6-9.

Published online: 4 October 2018

DOI: https://doi.org/10.4166/kjg.2018.72.1.6

Clinical Practice Guideline for Common Bile Duct Stones: Diagnosis and Treatment

Sung III Jang, Dong Ki Lee

Department of Internal Medicine, Institute of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Correspondence to: Dong Ki Lee, Department of Internal Medicine, Institute of Gastroenterology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 06273, Korea. Tel: +82-2-2019-3214, Fax: +82-2-3463-3882, E-mail: dklee@yuhs.ac

Received 18 June 2018 Revised 29 June 2018 Accepted 29 June 2018

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Common bile duct (CBD) stone is a biliary disease with an increasing incidence in Korea. Many advances have been made in diagnosis and treatment according to the development of imaging equipment and various devices to diagnose and treat CBD stones. The Korean Society for Pancreatobiliary Association has developed clinical practice guidelines for the diagnosis and treatment of CBD stones to assist clinicians in their management. The guidelines were divided into three parts: evaluation of CBD stones, endoscopic management of CBD stones, and endoscopic management of difficult and recurrent CBD stones. The purpose of this review is to summarize and present the diagnosis and treatment guidelines for CBD stones established in Korea.

Keywords: Choledocholithiasis, Diagnosis, Therapy, Guideline

References

1. Kim TH, Hwang JC, Kim JH, Kim YS, Kim DU, Seo DW. Clinical practice guidelines for common bile duct stones: purpose and process of guideline development. Korean J Pancreas Biliary Tract. 2013; 18:1–5.

2. Kim YS, Choi YW, Kim TH, Lee TH. Clinical practice guidelines for common bile duct stones: the evaluation of CBD stones. Korean J Pancreas Biliary Tract. 2013; 18:6–12.

3. Kim DW, Park ET, Choi JS. Clinical practice guidelines for common bile duct stones: the endoscopic management of CBD stones. Korean J Pancreas Biliary Tract. 2013; 18:13–20.

4. Hwang JC, Koh DH, Choi HJ. Clinical practice guidelines for common bile duct stones: the endoscopic management of difficult and recurrent common bile duct stones. Korean J Pancreas Biliary Tract. 2013; 18:21–28.

5. ASGE Standards of Practice Committee. Maple JT, Ben-Menachem T, et al. The role of endoscopy in the evaluation of suspected choledocholithiasis. Gastrointest Endosc. 2010; 71:1–9.

6. ASGE Standards of Practice Committee. Maple JT, Ikenberry SO, et al. The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 2011; 74:731–744.

7. Williams EJ, Green J, Beckingham I, et al. Guidelines on the management of common bile duct stones (CBDS). Gut. 2008; 57:1004–1021.

8. Schünemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008; 336:1106–1110.

9. Anciaux ML, Pelletier G, Attali P, Meduri B, Liguory C, Etienne JP. Prospective study of clinical and biochemical features of symptomatic choledocholithiasis. Dig Dis Sci. 1986; 31:449–453.

10. Abboud PA, Malet PF, Berlin JA, et al. Predictors of common bile duct stones prior to cholecystectomy: a metaanalysis. Gastrointest Endosc. 1996; 44:450–455.

11. Einstein DM, Lapin SA, Ralls PW, Halls JM. The insensitivity of sonography in the detection of choledocholithiasis. AJR Am J Roentgenol. 1984; 142:725–728.

12. Soto JA, Alvarez O, Munera F, Velez SM, Valencia J, Ramirez N. Diagnosing bile duct stones: comparison of unenhanced helical CT, oral contrast-enhanced CT cholangiography, and MR cholangiography. AJR Am J Roentgenol. 2000; 175:1127–1134.

13. Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a metaanalysis of test performance in suspected biliary disease. Ann Intern Med. 2003; 139:547–557.

14. Kondo S, Isayama H, Akahane M, et al. Detection of common bile duct stones: comparison between endoscopic ultrasonography, magnetic resonance cholangiography, and helical-computed-tomographic cholangiography. Eur J Radiol. 2005; 54:271–275.

15. Shaw MJ, Mackie RD, Moore JP, et al. Results of a multicenter trial using a mechanical lithotripter for the treatment of large bile duct stones. Am J Gastroenterol. 1993; 88:730–733.

16. Ersoz G, Tekesin O, Ozutemiz AO, Gunsar F. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc. 2003; 57:156–159.

17. Cotton PB, Forbes A, Leung JW, Dineen L. Endoscopic stenting for long-term treatment of large bile duct stones:2- to 5-year fol-low-up. Gastrointest Endosc. 1987; 33:411–412.

18. Hawes RH, Cotton PB, Vallon AG. Follow-up 6 to 11 years after duodenoscopic sphincterotomy for stones in patients with prior cholecystectomy. Gastroenterology. 1990; 98:1008–1012.

TOOLS

Similar articles